Prices as of 2025-11-28 16:15:41 ET
Ticker Appearances
Technical Strategy
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
March likely to be better than average given prior 4 months having turned in positive performance
EQUITY TRENDS SHOW NO EVIDENCE OF WAVERING. FEBRUARY MANAGED TO FINISH WITH GAINS GREATER THAN 5% ON THE HEELS OF THREE PRIOR MONTHS OF GAINS,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
Japan’s NKY breaks out, while US Semiconductors & Homebuilders weaken
US EQUITY INDICES AND TREASURY YIELDS REMAIN QUITE CHOPPY, BUT THE WEAKNESS COINCIDING WITH YIELDS PUSHING UP STILL LOOKS TO EXTEND INTO NEXT WEEK. TRENDS...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
Natural Gas & NIKKEI both look appealing for gains
The persistent melt-up for US Equities has been far more resilient than I expected to end the week, showing little to no evidence of turning...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Technical Strategy
Biotech bounce a welcome development for Healthcare
Sideways consolidation still ongoing for US equities and no real technical takeawayDollar/Yen rally could bring about Japanese Equity outperformanceBiotech bounce is a positive for Healthcare...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Technical Strategy
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
March likely to be better than average given prior 4 months having turned in positive performance
EQUITY TRENDS SHOW NO EVIDENCE OF WAVERING. FEBRUARY MANAGED TO FINISH WITH GAINS GREATER THAN 5% ON THE HEELS OF THREE PRIOR MONTHS OF GAINS,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
Japan’s NKY breaks out, while US Semiconductors & Homebuilders weaken
US EQUITY INDICES AND TREASURY YIELDS REMAIN QUITE CHOPPY, BUT THE WEAKNESS COINCIDING WITH YIELDS PUSHING UP STILL LOOKS TO EXTEND INTO NEXT WEEK. TRENDS...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Daily Technical Strategy
Natural Gas & NIKKEI both look appealing for gains
The persistent melt-up for US Equities has been far more resilient than I expected to end the week, showing little to no evidence of turning...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Technical Strategy
Biotech bounce a welcome development for Healthcare
Sideways consolidation still ongoing for US equities and no real technical takeawayDollar/Yen rally could bring about Japanese Equity outperformanceBiotech bounce is a positive for Healthcare...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Technical Strategy
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You have viewed the limit of 0/2 complimentary reports this month.
Visitor: c832eb-c23d8e-98b18a-f46596-130190 Array ( [cookie] => c832eb-c23d8e-98b18a-f46596-130190 [current_usage] => 0 [max_usage] => 2 [current_usage_crypto] => 0 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.43 )
Articles Read 0/2
🎁 Unlock 1 extra article by joining our Community!
Stay up to date with the latest articles. You’ll even get special recommendations weekly.
Already have an account? Sign In c832eb-c23d8e-98b18a-f46596-130190
Already have an account? Sign In c832eb-c23d8e-98b18a-f46596-130190